Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Physiol Heart Circ Physiol ; 305(7): H1057-67, 2013 Oct 01.
Article in English | MEDLINE | ID: mdl-23873801

ABSTRACT

Recent data indicate the brain angiotensin-converting enzyme/ANG II/AT1 receptor axis enhances emotional stress responses. In this study, we investigated whether its counterregulatory axis, the angiotensin-converting enzyme 2 (ACE2)/ANG-(1-7)/Mas axis, attenuate the cardiovascular responses to acute emotional stress. In conscious male Wistar rats, the tachycardia induced by acute stress (air jet 10 l/min) was attenuated by intravenous injection of ANG-(1-7) [Δ heart rate (HR): saline 136 ± 22 vs. ANG-(1-7) 61 ± 25 beats/min; P < 0.05]. Peripheral injection of the ACE2 activator compound, XNT, abolished the tachycardia induced by acute stress. We found a similar effect after intracerebroventricular injections of either ANG-(1-7) or XNT. Under urethane anesthesia, the tachycardia evoked by the beta-adrenergic agonist was markedly reduced by ANG-(1-7) [ΔHR: saline 100 ± 16 vs. ANG-(1-7) 18 ± 15 beats/min; P < 0.05]. The increase in renal sympathetic nerve activity (RSNA) evoked by isoproterenol was also abolished after the treatment with ANG-(1-7) [ΔRSNA: saline 39% vs. ANG-(1-7) -23%; P < 0.05]. The tachycardia evoked by disinhibition of dorsomedial hypothalamus neurons, a key nucleus for the cardiovascular response to emotional stress, was reduced by ∼45% after intravenous injection of ANG-(1-7). In cardiomyocyte, the incubation with ANG-(1-7) (1 µM) markedly attenuated the increases in beating rate induced by isoproterenol. Our data show that activation of the ACE2/ANG-(1-7)/Mas axis attenuates stress-induced tachycardia. This effect might be either via the central nervous system reducing anxiety level and/or interfering with the positive chronotropy mediated by activation of cardiac ß adrenergic receptors. Therefore, ANG-(1-7) might contribute to reduce the sympathetic load to the heart during situations of emotional stress, reducing the cardiovascular risk.


Subject(s)
Angiotensin I/pharmacology , Hemodynamics/drug effects , Peptide Fragments/pharmacology , Peptidyl-Dipeptidase A/metabolism , Proto-Oncogene Proteins/agonists , Receptors, G-Protein-Coupled/agonists , Signal Transduction/drug effects , Stress, Psychological/drug therapy , Tachycardia/prevention & control , Adrenergic beta-Agonists/pharmacology , Angiotensin I/administration & dosage , Angiotensin-Converting Enzyme 2 , Animals , Arterial Pressure/drug effects , Cells, Cultured , Disease Models, Animal , Dose-Response Relationship, Drug , Enzyme Activation , Enzyme Activators/pharmacology , Heart Rate/drug effects , Hypothalamus/drug effects , Hypothalamus/metabolism , Hypothalamus/physiopathology , Injections, Intravenous , Injections, Intraventricular , Male , Myocytes, Cardiac/drug effects , Myocytes, Cardiac/metabolism , Peptide Fragments/administration & dosage , Proto-Oncogene Mas , Proto-Oncogene Proteins/metabolism , Rats , Rats, Wistar , Receptors, G-Protein-Coupled/metabolism , Stress, Psychological/complications , Stress, Psychological/metabolism , Stress, Psychological/physiopathology , Sympathetic Nervous System/drug effects , Sympathetic Nervous System/metabolism , Sympathetic Nervous System/physiopathology , Tachycardia/etiology , Tachycardia/metabolism , Tachycardia/physiopathology
2.
Br J Pharmacol ; 144(6): 755-60, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15685215

ABSTRACT

1. Studies have shown that the angiotensin II (Ang II) AT1 receptor antagonist, losartan, accentuates the orthostatic hypotensive response in anesthetized rats, and there is evidence indicating that this effect is not exclusively mediated by AT1 receptors. 2. We investigated whether the pronounced orthostatic cardiovascular response observed in losartan-treated rats involves an interference with angiotensin-(1-7) (Ang-(1-7)) receptors. 3. Urethane-anesthetized rats were submitted to orthostatic stress (90 degree head-up tilt for 2 min). Intravenous injection of losartan (1 mg kg(-1), n=9) significantly accentuated the decrease in mean arterial pressure (MAP) induced by head-up tilt (-33+/-6% after losartan vs -15+/-8% control tilt). This effect was accompanied by a significant bradycardia (-8+/-3% after losartan vs -3+/-3% control tilt). Another AT1 antagonist, candesartan, did not potentiate the decrease of MAP and did not change the cardiac response induced by head-up tilt. Strikingly, administration of the Ang-(1-7) antagonist, A-779 (10 nmol kg(-1), n=5), totally reversed the bradycardic effect caused by losartan and this effect was accompanied by a tendency towards attenuation of the hypotensive response caused by losartan. 4. These findings indicate that the marked orthostatic cardiovascular response is specific for losartan, and that it may be due, in part, to an interaction of this antagonist with Ang-(1-7) receptors, probably at the cardiac level.


Subject(s)
Angiotensin II Type 1 Receptor Blockers/pharmacology , Angiotensin II/analogs & derivatives , Angiotensin Receptor Antagonists , Cardiovascular System/drug effects , Hypotension, Orthostatic/chemically induced , Losartan/pharmacology , Angiotensin II/antagonists & inhibitors , Angiotensin II/pharmacology , Animals , Blood Pressure/drug effects , Bradycardia/chemically induced , Male , Peptide Fragments/pharmacology , Rats , Rats, Wistar , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...